Global Biosimilar Pipeline and Market Prospects: MIR Research’s latest report, “Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design” provides an in-depth assessment of the current trends in the global biosimilars market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics that include data split by therapy area, stage of development, molecular target, clinical trials and company. Global revenue forecasts to 2022 for biosimilars with strong market potential, both in development and in the market, are provided.

Avail a sample copy before purchase:

The complex requirements of manufacturing biological drugs also apply to biosimilars, and these have been a significant barrier to the further expansion of the biosimilars market. A key challenge has been the knowledge gap under which biosimilars are developed, which arises from the fact that innovator product information remains proprietary and biosimilar manufacturers must adopt a reverse engineering process. Our new study assesses this and other significant manufacturing challenges, and how strategies based on quality initiatives and risk management can help address these issues.

Data analyses from our study show there will be enormous commercial opportunities for biosimilar developers over the coming years, given the number of high-revenue-generating biologics that will go off patent before 2020, and promising revenue forecasts for biosimilars in late-stage development. Information leveraged from our robust industry-leading database highlights a diverse number of biosimilars in the pipeline for a wide range of therapy areas, with several of these in the later stages of development. Case studies showcasing strategies adopted by leading pharmaceutical companies to compete in the biosimilars market are also provided.


– What is the distribution of pipeline biosimilars by stage of development?
– Which are the therapy areas set to benefit the most from biosimilar drugs in development?
– In biosimilar development, what are the most common molecular targets for key therapy areas?
– How many companies are currently involved in biosimilar drug development, which are the most active and what is the level of specialization across the development landscape?
– What was the volume of biosimilar clinical trials from 2006 to 2016, by therapy area and stage of development?
– What is the average biosimilar clinical trial size and duration across different stages of development, and across the immunology and oncology therapy areas?
– How much revenue will promising biosimilar drugs in the market, and in development, record to 2022?
– What are the key factors driving growth in the global biosimilars market?

Avail complete report of this research with TOC and List of Figures at:

Key Reasons to Purchase:
This report will allow you to –
– Gain insightful analyses and comprehensive understanding of the global biosimilar R&D and commercial landscape
– Assess biosimilar production processes, key issues and ways to mitigate development risk
– Understand the most important driving and restraining forces in the global biosimilars market
– Learn about biosimilar strategies being adopted by leading pharmaceutical companies.
– Understand the future outlook and prospects for biosimilar drugs

About Us:- MarketInsightsReports provides syndicated Market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth Market research studies i.e. Market share analysis, industry analysis, information on products, countries, Market size, trends, business research details and much more. MarketInsightsReports provides global and regional Market intelligence coverage, a 360-degree Market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

+1 (704) 266-3234 | mailto:  Sales

Connect With us On: